Aller au contenu principal
Profil bibliographique

Ana C. Chang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

15Publications signalées
296Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19Immune responses and vaccinationsViral gastroenteritis research and epidemiology

Les publications récentes

Accès ouvert 2026 article OpenAlex

Early immune events during SARS-CoV-2 infection impact memory T and B cell responses

Kyra Woloszczuk, David Joyner, Jennifer Connors, Mariana Bernui et autres

Immune responses elicited by natural infection of the coronavirus SARS-CoV-2 (COVID-19) show significant heterogeneity in the magnitude and quality of memory T and B cell responses. However, little is known about the contributing factors. In this study, we investigated the early immune …

us, nl, ca (code pays fourni par la source)

0 citations Communications Biology
Accès ouvert 2026 article OpenAlex

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, Annmarie Hoch et autres

The post-acute sequelae of SARS-CoV-2 (PASC), also known as long COVID, remain a significant health issue that is incompletely understood. Predicting which acutely infected individuals will develop long COVID is challenging due to the absence of established biomarkers, clear disease mechanisms, or …

Égypte, us, ca (code pays fourni par la source)

3 citations Communications Medicine
Accès ouvert 2025 article OpenAlex

Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS

Ana Carolina Monteiro, Harry C. Pickering, Aartik A. Sarma, Clove S. Taylor et autres

BACKGROUND: Elevated circulating endothelial cells (CECs), released from monolayers after insult, have been implicated in worse outcomes in ARDS and COVID-19, however there is no consensus proteomic phenotype that define CECs. We queried whether a transcriptomic approach would alternatively support the presence …

us (code pays fourni par la source)

2 citations Critical Care
Accès ouvert 2025 article OpenAlex

Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers

Joann Diray‐Arce, Ana C. Chang, Sara Moradipoor, Donato Amodio et autres

The International Network of Special Immunization Services (INSIS) was established to investigate the causes and risk factors of rare adverse events following immunizations (AEFIs) and develop immunization strategies for mitigating or preventing risk for individuals with prior AEFIs or at risk of …

us, ca, it, au, Afrique du Sud, nz, in (code pays fourni par la source)

4 citations Vaccine
Accès ouvert 2025 article OpenAlex

Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients

Harry C. Pickering, Joanna M. D. Schaenman, Hoang Van Phan, Cole P. Maguire et autres

Coronavirus disease 2019 (COVID-19) poses significant risks for solid organ transplant recipients, who have atypical but poorly characterized immune responses to infection. We aim to understand the host immunologic and microbial features of COVID-19 in transplant recipients by leveraging a prospective multicenter …

us (code pays fourni par la source)

6 citations Nature Communications
Accès ouvert 2024 article OpenAlex

Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, Ahmed Mostafa et autres

SARS-CoV-2 continues to be a public health burden, driven in-part by its continued antigenic diversification and resulting emergence of new variants. By increasing herd immunity, current vaccines have improved infection outcomes for many. However, prophylactic and treatment interventions that are not compromised …

us, Égypte, mn (code pays fourni par la source)

10 citations npj Viruses
Accès ouvert 2024 preprint OpenAlex

Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, Ahmed Mostafa et autres

SARS-CoV-2 continues to be a public health burden, driven in-part by its continued antigenic diversification and resulting emergence of new variants. While increasing herd immunity, current vaccines, and therapeutics have improved outcomes for some; prophylactic and treatment interventions that are not compromised …

us, Égypte (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 article OpenAlex

Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology

Hoang Van Phan, Alexandra Tsitsiklis, Cole P. Maguire, Elias K. Haddad et autres

Age is a major risk factor for severe coronavirus disease 2019 (COVID-19), yet the mechanisms behind this relationship have remained incompletely understood. To address this, we evaluated the impact of aging on host immune response in the blood and the upper airway, …

us (code pays fourni par la source)

27 citations Science Translational Medicine
Accès ouvert 2024 article OpenAlex

IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition

Benjamin Samuel Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, Jennifer R Connors et autres

The glycosylation of IgG plays a critical role during human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activating immune cells and inducing cytokine production. However, the role of IgM N-glycosylation has not been studied during human acute viral infection. The analysis …

us, ca (code pays fourni par la source)

29 citations Nature Communications
Accès ouvert 2024 article OpenAlex

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

Al Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, Esther C. Melamed et autres

Post-acute sequelae of SARS-CoV-2 (PASC) is a significant public health concern. We describe Patient Reported Outcomes (PROs) on 590 participants prospectively assessed from hospital admission for COVID-19 through one year after discharge. Modeling identified 4 PRO clusters based on reported deficits (minimal, …

us, ca (code pays fourni par la source)

62 citations Nature Communications
Accès ouvert 2023 article OpenAlex

Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

Joann Diray‐Arce, Slim Fourati, Naresh Doni Jayavelu, Ravi Kumar Patel et autres

The IMPACC cohort, composed of >1,000 hospitalized COVID-19 participants, contains five illness trajectory groups (TGs) during acute infection (first 28 days), ranging from milder (TG1-3) to more severe disease course (TG4) and death (TG5). Here, we report deep immunophenotyping, profiling of >15,000 …

us (code pays fourni par la source)

59 citations Cell Reports Medicine
Accès ouvert 2022 article OpenAlex

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study

Al Ozonoff, Joanna M. D. Schaenman, Naresh Doni Jayavelu, Carly E. Milliren et autres

BACKGROUND: Better understanding of the association between characteristics of patients hospitalized with coronavirus disease 2019 (COVID-19) and outcome is needed to further improve upon patient management. METHODS: Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) is a prospective, observational study of 1164 patients …

us (code pays fourni par la source)

75 citations EBioMedicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.